Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This pilot clinical trial studies the COMFORT (C-Communication, O-Orientation and opportunity, M-Mindful presence, F-Family, O-Openings, R-Relating, and T-Team) caregiver intervention in improving communication and reducing distress in caregivers of patients with lung cancer. Caregivers of patients with cancer may experience stress and anxiety due to difficulty communicating with family, friends, and healthcare providers, or feeling unable to communicate openly. A communication intervention that improves the caregiver's ability to communicate with patients and healthcare providers may help reduce caregivers' psychological distress and improve the health outcomes of patients.
Full description
PRIMARY OBJECTIVES:
I. To assess the feasibility of the COMFORT Caregiver Intervention (CCI) for family caregivers.
II. To explore common family caregiver communication concerns in oncology and their impact.
III. Estimate the effects of the CCI on family caregivers' psychological distress (primary outcome) and caregiver confidence with communication (secondary outcome).
OUTLINE:
Participants receive the printed communication tool "A Communication Guide for Caregivers," a guide developed from the COMFORT communication curriculum, a national training program for palliative care communication. After a 1 week period to review the material, participants undergo communication coaching with a research nurse by phone over approximately 1 hour.
After completion of the study, caregivers are followed up at 1 month to complete questionnaires and rate their satisfaction with the intervention.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Family caregivers will need to be the primary family caregiver as identified by the lung cancer patient (ten caregivers from each of the following cancer care continuum points will be recruited)
English-speaking
Cancer care continuum points are defined as follows:
All subjects must have the ability to understand and the willingness to participate in the informed consent process
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
50 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal